Yuyu to acquire stocks of U. S. SmartBio Science Inc.

Published: 2005-10-17 06:59:00

Updated: 2005-10-17 06:59:00

Yuyu and Crystal Genomics announced on Oct 12 that they jointly made an investment to SmartBio Science, a U. S. bio venture company seeking new drugs for Alzheimer disease and cancer. The investment was in money by Yuyu and in technologies by Crystal Geneomics.

Crystal Genomics made an MOU agr...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK